Objective. Most clinicians use the 2006 Sydney classification criteria to evaluate patients
suspected of having antiphospholipid syndrome (APS). Although sensitive and specific for …

Accurate diagnosis of obstetric antiphospholipid syndrome (APS) is a prerequisite for
optimal clinical management. The international consensus (revised Sapporo) criteria for …

Objectives: To evaluate the clinical accuracy of antiphospholipid antibody (aPL) specificities
both individually and/or in combination, in a wide cohort of systemic lupus erythematosus …

Objective To examine the prevalence of isolated IgA anti–β2‐glycoprotein I (anti‐β2GPI)
positivity and the association of these antibodies, and a subgroup that bind specifically to …

APS is an autoimmune disease that leads to arterial and/or venous thrombosis, recurrent
pregnancy loss and persistently positive aPLs. Patients with clinical manifestations highly …

Objective Antiphospholipid antibodies (aPL) are related to poor pregnancy outcomes, but
their effect on embryo implantation is unclear. We aimed to assess the prevalence of …

Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by frequent
clotting in arteries and veins and/or miscarriages. Autoantibodies to phospholipids and to …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LAC), anticardiolipin …

The international classification criteria for definite antiphospholipid syndrome (APS) include
three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti …